Next Article in Journal
4-{[(4-Methylphenyl)imino]methyl}-3-hydroxyphenyl 4-(Hexadecanoyloxy)benzoate
Previous Article in Journal
Anthracen-9-ylmethylene-(3,4-dimethylisoxazol-5-yl)amine
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

2-tert-Butyl-5,6,7,8,9,10-hexahydrocyclohepta[b]indole

Institut für Medizinische und Pharmazeutische Chemie, Technische Universität Braunschweig, Beethovenstr. 55, 38106 Braunschweig, Germany
*
Author to whom correspondence should be addressed.
Molbank 2011, 2011(3), M737; https://doi.org/10.3390/M737
Submission received: 17 August 2011 / Accepted: 20 September 2011 / Published: 21 September 2011

Abstract

:
2-tert-Butyl-5,6,7,8,9,10-hexahydrocyclohepta[b]indole was synthesized by reaction of cycloheptanone and (4-tert-butylphenyl)hydrazine hydrochloride in the presence of sodium acetate and sulfuric acid in glacial acetic acid via Fischer indole synthesis.

Graphical Abstract

Paullones are an established class of protein kinase inhibitors based on the 7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one molecular scaffold. As commercially available agents paullones are widely used as biochemical tools. Among other biological properties, paullones have demonstrated antiproliferative activity on cancer cell lines on the one hand [1,2,3,4,5] and protection of insulin producing pancreatic beta cells against apoptosis on the other hand [6]. Recently paullone chalcone hybrid structures 1 were reported to inhibit the growth of Leishmania amastigotes in vitro [7]. In order to study structure-activity relationships regarding this antiparasitic activity congeners related to 1 are currently investigated. In the course of these studies we were interested in 2-tert-butyl-5,6,7,8,9,10-hexahydrocyclohepta[b]indole (2) representing the tert-butyl substituted indole fragment reminiscent of the paullone substructure in 1. A thorough survey of the literature revealed that 2 was hitherto unknown.
The synthesis of 2 was accomplished by a straightforward Fischer indole synthesis [8,9] protocol from cycloheptanone (3) and (4-tert-butylphenyl)hydrazine hydrochloride (4).
Molbank 2011 m737 i001
In order to identify suitable reaction conditions an equimolar amount of the reactants 3, 4 and sodium acetate in glacial acetic acid were stirred at 70 °C in the presence of a catalytic amount of concentrated sulfuric acid yielding 64% of the desired product. Higher reaction temperatures led to a slightly increased yield but produced small amounts of unidentified side products which were cumbersome to remove. Modifications of reaction temperature and ratio of reactants led to an optimized procedure. Eventually, a protocol was established in which a 2.0 mmol: 2.4 mmol mixture of 3 and 4 was stirred for overall 4 h at 70 °C with addition of sulfuric acid after 1 h. This method yielded 75% (72–79%) as an average of two reruns.
Molbank 2011 m737 i002

Experimental

General

(4-tert-Butylphenyl)hydrazine hydrochloride was purchased from Sigma-Aldrich and cycloheptanone from Acros Organics. Melting points were determined in open-glass capillaries on an electric variable heater (Electrothermal IA 9100). FT-IR absorption spectra were recorded on a Thermo Nicolet FT-IR 200 spectrometer using KBr pellets. 1H-NMR and 13C-NMR spectra were recorded on a Bruker Avance DRX-400 (NMR laboratories of the Chemical Institutes of the Technische Universität Braunschweig) using DMSO-d6 as solvent. Chemical shifts are reported as parts per million (ppm) downfield from TMS used as an internal standard. The elemental analysis was recorded on a CE Instruments FlashEA® 1112 Elemental Analyzer. The reaction was monitored by TLC (Macherey-Nagel Polygram SIL G/UV254) using toluene/ethyl acetate mixtures as eluent. The mass spectrum was recorded on a ThermoFisher Scientific LTQ-Orbitrap Velos (department of mass spectrometry of the Chemical Institutes of the Technische Universität Braunschweig). HPLC was performed on a Merck Hitachi LaChrom Elite system (pump: L-2130, DAD detector: L-2450; autosampler: L-2200; column: Merck LiChroCART 125-4, LiChrospher 100 RP-18 (5 μm); eluent: acetonitrile/water mixture (70:30), elution rate 1.000 mL/min; detection wavelength: 254 nm and 280 nm; overall run time: 15 min.); tms = total retention time, ts = dead time.

2-tert-Butyl-5,6,7,8,9,10-hexahydrocyclohepta[b]indole

A mixture of cycloheptanone (3) (0.224 g; 2.00 mmol), (4-tert-butylphenyl)hydrazine hydrochloride (4) (0.482 g; 2.40 mmol) and sodium acetate (0.197g; 2.40 mmol) was stirred in glacial acetic acid (10 mL) for 1 h at 70 °C. Subsequently, concentrated sulfuric acid (0.05 mL) was added and stirring was continued at 70 °C for 3 h. After cooling to room temperature the mixture was poured into 5% sodium acetate solution (40 mL). A solid precipitated upon standing over night at 8 °C which was filtered and dried at 60 °C for 2 h. Crystallization from water/ethanol (50:50, v/v) yielded 0.35–0.38 g (72–79%) of brownish crystals.
Mp 129–131 °C.
MS (ESI – MeOH, + Mod, rel. intensity): m/z: 242.19026 ([M+H]+, 100).
IR (KBr) cm−1: 3397 (N-H); 2963 (C-H, aliph.); 2922 (C-H, aliph.).
1H NMR (400 MHz, DMSO-d6): 1.31 (s, 9H, CH3), 1.63–1.71 (m, 4H, CH2), 1.80–1.87 (m, 2H, CH2), 2.70–2.81 (m, 4H, CH2), 7.03 (dd, 1H, J = 1.86, 8.47, C(3)-H), 7.12 (dd, 1H, J = 0.43, 8.38, C(4)-H), 7.30 (d, 1H, J = 1.79, C(1)-H), 10.46 (s, 1H, NH).
13C NMR (100 MHz, DMSO-d6) δ: 24.22 (CH2), 27.27 (CH2), 28.55 (CH2), 28.65 (CH2), 31.55 (CH2), 31.91 (CH3), 34.15 (CH), 109.81 (CH), 111.77 (C quat), 112.57 (CH), 117.59 (CH), 128.29 (C quat), 132.22 (C quat), 137.94 (C quat), 140.12 (C quat).
HPLC (AUC %): 96.6% at 254 nm; 98.3% at 280 nm, tms = 7.71 min, ts (DMSO) = 1.07 min.
Anal. calcd. for C17H23N: C, 84.59; H, 9.60; N, 5.80. Found: C, 84.36; H, 9.49; N, 5.55.

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

Acknowledgments

The authors are grateful to U. Papke for recording the ESI mass spectrum. This joint research project was financially supported by the State of Lower Saxony, Hannover, Germany.

References and Notes

  1. Kunick, C.; Zeng, Z.; Gussio, R.; Zaharevitz, D.; Leost, M.; Totzke, F.; Schächtele, C.; Kubbutat, M.H.G.; Meijer, L.; Lemcke, T. Structure-aided optimization of kinase inhibitors derived from alsterpaullone. ChemBioChem 2005, 6, 541–549. [Google Scholar] [CrossRef] [PubMed]
  2. Lahusen, T.; De Siervi, A.; Kunick, C.; Senderowicz, A.M. Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase 9 due to perturbation in mitochondrial membrane potential. Mol. Carcinog. 2003, 36, 183–194. [Google Scholar] [CrossRef] [PubMed]
  3. Pies, T.; Schaper, K.-J.; Leost, M.; Zaharevitz, D.W.; Gussio, R.; Meijer, L.; Kunick, C. CDK1-inhibitory activity of paullones depends on electronic properties of 9-substituents. Arch. Pharm. Pharm. Med. Chem. 2004, 337, 486–492. [Google Scholar] [CrossRef] [PubMed]
  4. Wieking, K.; Knockaert, M.; Leost, M.; Zaharevitz, D.W.; Meijer, L.; Kunick, C. Synthesis of paullones with aminoalkyl side chains. Arch. Pharm. Pharm. Med. Chem. 2002, 335, 311–317. [Google Scholar] [CrossRef]
  5. Xie, X.; Lemcke, T.; Gussio, R.; Zaharevitz, D.W.; Leost, M.; Meijer, L.; Kunick, C. Epoxide-containing side chains enhance antiproliferative activity of paullones. Eur. J. Med. Chem. 2005, 40, 655–661. [Google Scholar] [CrossRef] [PubMed]
  6. Stukenbrock, H.; Mussmann, R.; Geese, M.; Ferandin, Y.; Lozach, O.; Lemcke, T.; Kegel, S.; Lomow, A.; Burk, U.; Dohrmann, C.; Meijer, L.; Austen, M.; Kunick, C. 9-Cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication. J. Med. Chem. 2008, 51, 2196–2207. [Google Scholar] [CrossRef] [PubMed]
  7. Reichwald, C.; Shimony, O.; Dunkel, U.; Sacerdoti-Sierra, N.; Jaffe, C.L.; Kunick, C. 2-(3-Aryl-3-oxopropen-1-yl)-9-tert-butyl-paullones: A new antileishmanial chemotype. J. Med. Chem. 2008, 51, 659–665. [Google Scholar] [CrossRef] [PubMed]
  8. Humphrey, G.R.; Kuethe, J.T. Practical methodologies for the synthesis of indoles. Chem. Rev. 2006, 106, 2875–2911. [Google Scholar] [CrossRef] [PubMed]
  9. Hughes, D.L. Progress in the Fischer indole reaction. A review. Org. Prep. Proced. Int. 1993, 25, 607–632. [Google Scholar] [CrossRef]

Share and Cite

MDPI and ACS Style

Falke, H.; Bumiller, K.; Harbig, S.; Masch, A.; Wobbe, J.; Kunick, C. 2-tert-Butyl-5,6,7,8,9,10-hexahydrocyclohepta[b]indole. Molbank 2011, 2011, M737. https://doi.org/10.3390/M737

AMA Style

Falke H, Bumiller K, Harbig S, Masch A, Wobbe J, Kunick C. 2-tert-Butyl-5,6,7,8,9,10-hexahydrocyclohepta[b]indole. Molbank. 2011; 2011(3):M737. https://doi.org/10.3390/M737

Chicago/Turabian Style

Falke, Hannes, Katharina Bumiller, Sabrina Harbig, Andreas Masch, Janina Wobbe, and Conrad Kunick. 2011. "2-tert-Butyl-5,6,7,8,9,10-hexahydrocyclohepta[b]indole" Molbank 2011, no. 3: M737. https://doi.org/10.3390/M737

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop